Quantitative measurement of medial femoral knee cartilage volume - analysis of the OA Biomarkers Consortium FNIH Study cohort.

OBJECTIVE Large studies of knee osteoarthritis (KOA) require well-characterized efficient methods to assess progression. We previously developed the local-area cartilage segmentation (LACS) software method, to measure cartilage volume on magnetic resonance imaging (MRI) scans. The present study further validates this method in a larger patient cohort and assesses predictive validity in a case-control study. METHOD The OA Biomarkers Consortium FNIH Project, a case-control study of KOA progression nested within the Osteoarthritis Initiative (OAI), includes 600 subjects in four subgroups based on radiographic and pain progression. Our software tool measured change in medial femoral cartilage volume in a central weight-bearing region. Different sized regions of cartilage were assessed to explore their sensitivity to change. The readings were performed on MRI scans at the baseline and 24-month visits. We used standardized response means (SRMs) for responsiveness and logistic regression for predictive validity. RESULTS Cartilage volume change was associated strongly with radiographic progression (odds ratios (OR) = 4.66; 95% confidence intervals (CI) = 2.85-7.62). OR were significant but of lesser magnitude for the combined radiographic and pain progression outcome (OR = 1.70; 95% CI = 1.40-2.07). For the full 600 subjects, theSRM was -0.51 for the largest segmented area. Smaller areas of cartilage segmentation were also able to predict the case-control status. The average reader time for the largest area was less than 20 min per scan. Smaller areas could be assessed with less reader time. CONCLUSION We demonstrated that the LACS method is fast, responsive, and associated with radiographic and pain progression, and is appropriate for existing and future large studies of KOA.

[1]  A Guermazi,et al.  Imaging for osteoarthritis. , 2016, Annals of physical and rehabilitation medicine.

[2]  Ali Guermazi,et al.  Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium , 2016, Arthritis & rheumatology.

[3]  A. Guermazi,et al.  Structural correlates of pain in joints with osteoarthritis. , 2013, Osteoarthritis and cartilage.

[4]  Ali Guermazi,et al.  Longitudinal validation of periarticular bone area and 3D shape as biomarkers for knee OA progression? Data from the FNIH OA Biomarkers Consortium , 2015, Annals of the rheumatic diseases.

[5]  J Duryea,et al.  Novel fast semi-automated software to segment cartilage for knee MR acquisitions. , 2007, Osteoarthritis and cartilage.

[6]  M. Nevitt,et al.  Biomarkers for osteoarthritis: current position and steps towards further validation. , 2014, Best practice & research. Clinical rheumatology.

[7]  W. Wirth,et al.  Brief Report: Cartilage Thickness Change as an Imaging Biomarker of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium , 2015, Arthritis & rheumatology.

[8]  F Eckstein,et al.  Imaging of cartilage and bone: promises and pitfalls in clinical trials of osteoarthritis. , 2014, Osteoarthritis and cartilage.

[9]  Ali Guermazi,et al.  Local Area Cartilage Segmentation: A Semiautomated Novel Method of Measuring Cartilage Loss in Knee Osteoarthritis , 2014, Arthritis care & research.

[10]  Felix Eckstein,et al.  Cartilage thickness change as an imaging biomarker of knee osteoarthritis progression – data from the fnih OA biomarkers consortium , 2015 .

[11]  J. Lynch,et al.  Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility , 2003, Skeletal Radiology.

[12]  B Madore,et al.  Integration of accelerated MRI and post-processing software: a promising method for studies of knee osteoarthritis. , 2016, Osteoarthritis and cartilage.

[13]  J. Raynauld,et al.  Assessment of Cartilage Changes Over Time in Knee Osteoarthritis Disease‐Modifying Osteoarthritis Drug Trials Using Semiquantitative and Quantitative Methods: Pros and Cons , 2013, Arthritis care & research.

[14]  F Eckstein,et al.  Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative , 2005, Annals of the rheumatic diseases.

[15]  A Guermazi,et al.  Changes in patellofemoral and tibiofemoral joint cartilage damage and bone marrow lesions over 7 years: the Multicenter Osteoarthritis Study. , 2016, Osteoarthritis and cartilage.

[16]  G. Lester,et al.  Clinical research in OA--the NIH Osteoarthritis Initiative. , 2008, Journal of musculoskeletal & neuronal interactions.

[17]  Erika Schneider,et al.  The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. , 2008, Osteoarthritis and cartilage.

[18]  A. Guermazi,et al.  The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston–Leeds Osteoarthritis Knee Score) , 2007, Annals of the rheumatic diseases.

[19]  Deborah Schofield,et al.  The individual and socioeconomic impact of osteoarthritis , 2014, Nature Reviews Rheumatology.

[20]  R. Boudreau,et al.  Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). , 2011, Osteoarthritis and cartilage.

[21]  H Yoshioka,et al.  Quantification of cartilage loss in local regions of knee joints using semi-automated segmentation software: analysis of longitudinal data from the Osteoarthritis Initiative (OAI). , 2009, Osteoarthritis and cartilage.

[22]  Ali Guermazi,et al.  Semi‐Quantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data from the FNIH OA Biomarkers Consortium , 2016 .